Viatris vs ElevenLabs

Side-by-side comparison of AI visibility scores, market position, and capabilities

AI visibility is closely matched (88 vs 84)
Viatris logo

Viatris

LeaderHealthcare Tech

Generic Pharmaceuticals

Viatris (VTRS) reported ~$15.4B revenue in FY2024. Global generic and specialty pharmaceutical company formed by Pfizer's Upjohn spinoff merging with Mylan. HQ: Canonsburg, PA.

AI VisibilityBeta
Overall Score
A88
Category Rank
#1 of 1
AI Consensus
58%
Trend
stable
Per Platform
ChatGPT
98
Perplexity
98
Gemini
88

About

Viatris Inc. is a global pharmaceutical company formed in 2020 through the combination of Pfizer's off-patent branded drug unit (Upjohn) and Mylan, one of the world's largest generic drug manufacturers. The company manufactures, licenses, and distributes approximately 1,400 approved molecules across branded generics, complex generics, and a portfolio of iconic off-patent brands including Lipitor (atorvastatin), Viagra (sildenafil), EpiPen, and Xanax (alprazolam) sold in markets where these brands retain meaningful recognition and premium pricing.

Full profile
ElevenLabs logo

ElevenLabs

ChallengerAI & Machine Learning

Voice AI

$500M Series D at $11B valuation (Feb 2026) — largest voice AI funding round ever. $330M ARR; 1M+ developers using the API. Enterprise customers: Deutsche Telekom, Revolut, Meta, Salesforce. Voices in 32 languages; real-time cloning from 1 second of audio.

AI VisibilityBeta
Overall Score
A84
Category Rank
#1 of 1
AI Consensus
64%
Trend
up
Per Platform
ChatGPT
79
Perplexity
89
Gemini
82

About

ElevenLabs was founded in 2022 by Piotr Dabkowski and Mati Staniszewski, two former Google and Palantir engineers who set out to break the language barrier using AI voice technology. The company specializes in AI-powered voice synthesis, cloning, and dubbing, enabling developers and enterprises to generate human-quality speech in over 30 languages. Its core technology combines deep learning models trained on massive speech datasets to produce natural-sounding voices indistinguishable from real humans.\n\nElevenLabs offers a suite of products including its flagship text-to-speech API, voice cloning tools, and an AI dubbing platform that localizes video content while preserving the speaker's original voice. Its products target a broad audience—from indie developers building audio apps to large enterprises deploying voice interfaces at scale. Key differentiators include ultra-low latency streaming synthesis, fine-grained voice customization, and a growing library of pre-built AI voices across accents and styles.\n\nElevenLabs has grown rapidly, surpassing $330M in annualized revenue and serving over 1 million developers. Enterprise clients include Deutsche Telekom, Spotify, and leading media companies. In February 2026, the company closed a $500M Series D at an $11B valuation, cementing its position as the market leader in AI voice. Its APIs power podcasts, audiobooks, video games, and customer service bots worldwide, making ElevenLabs the default infrastructure layer for AI-generated audio.

Full profile

AI Visibility Head-to-Head

88
Overall Score
84
#1
Category Rank
#1
58
AI Consensus
64
stable
Trend
up
98
ChatGPT
79
98
Perplexity
89
88
Gemini
82
88
Claude
75
82
Grok
88

Key Details

Category
Generic Pharmaceuticals
Voice AI
Tier
Leader
Challenger
Entity Type
company
brand

Capabilities & Ecosystem

Capabilities

Only Viatris
Generic Pharmaceuticals
Only ElevenLabs
Voice AI

Integrations

Only Viatris
Only ElevenLabs
Viatris is classified as company (part of Pfizer).

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.